Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination. | Science | 2022 | 35143256 | PubTator, text mining | PubMed |
| The clinicopathological and prognostic significances of LATS1 expression in breast cancer. | Histol Histopathol | 2022 | 35142365 | PubTator, text mining | PubMed |
| Targeting PLA2G16, a lipid metabolism gene, by Ginsenoside Compound K to suppress the malignant progression of colorectal cancer. | J Adv Res | 2022 | 35127176 | PubTator, text mining | PubMed |
| ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation. | Nat Commun | 2022 | 35121738 | PubTator, text mining | PubMed |
| The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer. | Clin Sci (Lond) | 2022 | 35119068 | PubTator, text mining | PubMed |
| Functions, mechanisms, and therapeutic implications of METTL14 in human cancer. | J Hematol Oncol | 2022 | 35115038 | PubTator, text mining | PubMed |
| Protein kinase Cα activation switches YAP1 from TEAD-mediated signaling to p73-mediated signaling. | Cancer Sci | 2022 | 35102644 | PubTator, text mining | PubMed |
| RNA-binding protein complex LIN28/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7. | Oncogene | 2022 | 35102250 | PubTator, text mining | PubMed |
| Hippo signalling in the liver: role in development, regeneration and disease. | Nat Rev Gastroenterol Hepatol | 2022 | 35064256 | PubTator, text mining | PubMed |
| HERC3 regulates epithelial-mesenchymal transition by directly ubiquitination degradation EIF5A2 and inhibits metastasis of colorectal cancer. | Cell Death Dis | 2022 | 35064108 | PubTator, text mining | PubMed |
| RICH1 inhibits breast cancer stem cell traits through activating kinases cascade of Hippo signaling by competing with Merlin for binding to Amot-p80. | Cell Death Dis | 2022 | 35064101 | PubTator, text mining | PubMed |
| Arrabidaea chica chloroform extract modulates estrogen and androgen receptors on luminal breast cancer cells. | BMC Complement Med Ther | 2022 | 35057779 | PubTator, text mining | PubMed |
| Apoptosis in Type 2 Diabetes: Can It Be Prevented? Hippo Pathway Prospects. | Int J Mol Sci | 2022 | 35054822 | PubTator, text mining | PubMed |
| The "LLQY" Motif on SARS-CoV-2 Spike Protein Affects S Incorporation into Virus Particles. | J Virol | 2022 | 35045269 | PubTator, text mining | PubMed |
| Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | Mol Syst Biol | 2022 | 35044719 | PubTator, text mining | PubMed |
| Hippo/YAP signaling pathway protects against neomycin-induced hair cell damage in the mouse cochlea. | Cell Mol Life Sci | 2022 | 35044530 | PubTator, text mining | PubMed |
| An allosteric regulation mechanism of Arabidopsis Serine/Threonine kinase 1 (SIK1) through phosphorylation. | Comput Struct Biotechnol J | 2022 | 35035789 | PubTator, text mining | PubMed |
| The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1. | Nat Cell Biol | 2022 | 35027733 | PubTator, text mining | PubMed |
| Towards targeting of shared mechanisms of cancer metastasis and therapy resistance. | Nat Rev Cancer | 2022 | 35013601 | PubTator, text mining | PubMed |
| Linking post-translational modifications and protein turnover by site-resolved protein turnover profiling. | Nat Commun | 2022 | 35013197 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=47